8-23224874-C-T
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_ModerateBS2
The NM_003844.4(TNFRSF10A):c.188G>A(p.Gly63Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000035 in 1,427,282 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_003844.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TNFRSF10A | NM_003844.4 | c.188G>A | p.Gly63Glu | missense_variant | 1/10 | ENST00000221132.8 | NP_003835.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TNFRSF10A | ENST00000221132.8 | c.188G>A | p.Gly63Glu | missense_variant | 1/10 | 1 | NM_003844.4 | ENSP00000221132 | P1 | |
TNFRSF10A | ENST00000613472.1 | c.31+157G>A | intron_variant | 1 | ENSP00000480778 | |||||
TNFRSF10A-DT | ENST00000517774.1 | n.404C>T | non_coding_transcript_exon_variant | 1/2 | 4 |
Frequencies
GnomAD3 genomes Cov.: 30
GnomAD4 exome AF: 0.00000350 AC: 5AN: 1427282Hom.: 0 Cov.: 31 AF XY: 0.00000283 AC XY: 2AN XY: 706874
GnomAD4 genome Cov.: 30
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 02, 2023 | The c.188G>A (p.G63E) alteration is located in exon 1 (coding exon 1) of the TNFRSF10A gene. This alteration results from a G to A substitution at nucleotide position 188, causing the glycine (G) at amino acid position 63 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at